<乌鸦传媒>Boys Who Lose Excess Pounds by College May Still See Elevated Cancer Risk Long-term Swedish study suggests early obesity "programming" in males has lasting impact Nov 04, 2022
<乌鸦传媒>Treatment De-Escalation Shows Promise in Testicular Cancer Early trial misses primary PFS endpoint, but "favorable" outcomes seen nonetheless Nov 03, 2022
<乌鸦传媒>Study: U.S. Chemo Regimen for Ewing Sarcoma Should Be International Standard Europe and other countries have already followed suit Nov 01, 2022
<乌鸦传媒>My Risk Revealed: A Confirmed BRCA2 Mutation My dad's cancer diagnosis offered me invaluable information Oct 30, 2022
<乌鸦传媒>Ablative MR-Guided RT Shows Promise in Pancreatic Cancer SMART safe in patients with borderline or locally advanced cancer, with encouraging early OS data Oct 27, 2022
<乌鸦传媒>Radiation for Asymptomatic Bone Metastases May Improve Cancer Survival Fewer skeletal events, less pain unexpectedly followed by longer life Oct 26, 2022
<乌鸦传媒>New Standard-of-Care Therapy for Advanced Liver Cancer Stereotactic body radiotherapy plus sorafenib improves survival versus targeted drug alone Oct 24, 2022
<乌鸦传媒>Rapid Radiotherapy Technique Shows Promise in First Human Trial FLASH relieved pain in most patients with bone metastases, with few side effects Oct 24, 2022
<乌鸦传媒>FDA Approves New CTLA-4 Inhibitor for Cancer Treatment Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
<乌鸦传媒>Is Your Oven Leaking Cancer-Causing Chemicals Into Your Kitchen? Study finds that natural gas leaks result in elevated benzene levels, even when stove not in use Oct 20, 2022
<乌鸦传媒>This One Risk Factor Dominates for Soft Tissue Sarcoma After Breast Cancer Risk is low but appears to have modifiable components Oct 13, 2022
<乌鸦传媒>Caregiving at the End Co-host Tyler Johnson talks with the husband of previous guest, Ellen Dunphy, who died in July Oct 11, 2022 podcast
<乌鸦传媒>More Evidence Backing Anti-CDK4/6-Based Therapy in Recurrent Endometrial Cancer Abemaciclib plus letrozole led to 30% objective response rate, 55.6% PFS rate at 6 months Oct 10, 2022
<乌鸦传媒>FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomas Local and regional illness remained unchanged Oct 04, 2022
<乌鸦传媒>Combo Therapy Shows Promise in Advanced Thymic Epithelial Tumors "Clinically remarkable outcomes" with PD-L1 inhibitor plus anti-angiogenesis agent Oct 04, 2022
<乌鸦传媒>SABR for Oligometastatic Cancer Turns in 'Acceptable' Rates of Toxicity Rates of grade 2 or higher toxicities less than those observed in landmark SABR-COMET study Oct 03, 2022
<乌鸦传媒>Adding Chemo Not Better for Recurrent Endometrial Cancer Trial suggests radiation therapy alone remains standard of care for pelvic-only recurrences Oct 03, 2022
<乌鸦传媒>Was I Conned by a 'Grey's Anatomy' Writer? Her alleged duplicity could make things tougher for female patients Sep 27, 2022
<乌鸦传媒>Cancer in Kids Tied to Prenatal Exposure to High-Dose Folic Acid and Seizure Meds But no link seen among children of mothers without epilepsy Sep 26, 2022
<乌鸦传媒>FDA Grants First Tumor-Agnostic Approval for RET Fusion-Positive Cancers Selpercatinib approved for advanced or metastatic solid tumors that progress on systemic therapy Sep 22, 2022
<乌鸦传媒>How Does Oncology Deal With Pandemic Burnout? Evidence suggests the pandemic could have long-term consequences Sep 20, 2022
<乌鸦传媒>Radiation Oncology Residents Report Deficits in Training During the Pandemic About half worry about job prospects Sep 19, 2022
<乌鸦传媒>How a Dedicated Bone Marrow Biopsy Clinic Eased Wait Times VA center in Cleveland got program up and running in about a month Sep 19, 2022
<乌鸦传媒>Is Cancer Therapy Also a Lupus Cure? Patients in pilot study show months-long complete remission Sep 15, 2022
<乌鸦传媒>Non-Chemo Regimen Led to High Response Rates in Cisplatin-Ineligible Bladder Cancer "Encouraging activity" with enfortumab vedotin-pembrolizumab in patients with high unmet need Sep 14, 2022
<乌鸦传媒>Add-On Pembrolizumab Misses in Locally Advanced Head and Neck Cancer Post hoc data point to possible benefit in patients with higher PD-L1 levels Sep 11, 2022
<乌鸦传媒>'Potential New Standard' for Progressing Desmoid Tumors Risk of disease progression or death reduced by 71% with oral gamma secretase inhibitor Sep 10, 2022
<乌鸦传媒>Robotic Surgery Tops Laparoscopic Surgery for Middle and Low Rectal Cancer Randomized trial shows fewer positive circumferential resection margins with robotic technique Sep 09, 2022
<乌鸦传媒>Coping With a Deadly Prognosis An impossible battle with the rarest of cancers Sep 06, 2022 podcast
<乌鸦传媒>10-Year Follow-Up Confirms Benefit of Chemoradiotherapy in MIBC Patients Findings "supported a change in clinical practice" Sep 01, 2022
<乌鸦传媒>Pralsetinib Shows Promise in Diverse RET Fusion-Positive Cancers An ORR of 57% supports results previously observed in NSCLC and thyroid cancer Aug 26, 2022
<乌鸦传媒>Intensive Endoscopy Might Not Be One-and-Done for Gastric Cancer Surveillance High-risk group had similar new lesion detection rates initially and at 15 months Aug 22, 2022
<乌鸦传媒>Florida Oncologist Presumed Lost at Sea The Coast Guard recently suspended its search for Chaundre Cross, MD, of Naples Aug 19, 2022
<乌鸦传媒>Patients With Head/Neck Cancer See Lower Stroke Risk With Initial Surgery Enough reason to prefer the scalpel to definitive radiotherapy? Aug 12, 2022
<乌鸦传媒>Epstein-Barr Virus Linked With Gastric Cancer Meta-analysis shows a 7.5% prevalence across 37 countries Aug 12, 2022
<乌鸦传媒>Study Confirms Big Drop in Power Morcellator Use, Shows Lag in Containment Systems But whether containment bags really work remains open to question, authors say Aug 11, 2022
<乌鸦传媒>Two Sides of Endosalpingiosis: Benign Growth or Harbinger of Cancer? Concurrent malignancy more than twice as common as compared with endometriosis, study showed Aug 06, 2022
<乌鸦传媒>Cluster of Physician Deaths at Canadian Hospital Spurs Misinfo Campaign All three doctors died from cancer, but became the subject of anti-vax social media posts Aug 05, 2022
<乌鸦传媒>Adding TACE to Lenvatinib Boosts Survival in Advanced Liver Cancer In China-based trial, overall survival in first-line improved by 6 months versus lenvatinib alone Aug 04, 2022
<乌鸦传媒>Hearing Loss Plagues Cancer Survivors No Matter the Type of Chemo Ototoxicity reported in more than half of study patients who got platinum, taxanes, or both Aug 03, 2022
